Park Medi World Q1 Results: Net profit rises 35% YoY to ₹886 million
Park Medi World Limited delivered strong Q1FY27 results with net profit jumping 35% YoY to ₹885.93 million. Revenue rose 19% to ₹4,757.09 million, while EBITDA grew 20% to ₹1,260.88 million. The Board approved the results on August 3, 2026, compliant with SEBI Listing Regulations.

*this image is generated using AI for illustrative purposes only.
Park Medi World Limited reported a significant improvement in profitability for the first quarter of FY27, with consolidated net profit after tax (PAT) rising 35% year-on-year to ₹885.93 million. The growth was underpinned by a 19% surge in revenue from operations, which reached ₹4,757.09 million for the quarter ended June 30, 2026, compared to ₹3,988.45 million in the corresponding period of FY26. This performance highlights the company’s ability to drive top-line growth while expanding operational margins.
The Board of Directors approved the unaudited standalone and consolidated financial results on August 3, 2026, following recommendations from the Audit Committee. In compliance with Regulation 33 read with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company published the results in ‘The Economic Times’ and ‘Navbharat Times’ on August 4, 2026. The financial statements were subjected to a limited review by the statutory auditor, who issued unmodified reports.
Financial Performance Overview
Key financial metrics for the quarter reflect robust operational execution across the company’s network of 17 hospitals and 4,290 beds. EBITDA increased by 20% year-on-year to ₹1,260.88 million, up from ₹1,049.31 million in Q1FY26. Profit before tax also saw substantial growth, rising to ₹1,050.84 million from ₹818.99 million in the previous year’s corresponding quarter.
| Particulars | Q1FY27 (Unaudited) | Q4FY26 (Audited) | Q1FY26 (Unaudited) |
|---|---|---|---|
| Revenue from operations | ₹4,757.09 million | ₹4,604.13 million | ₹3,988.45 million |
| EBITDA | ₹1,260.88 million | ₹1,273.68 million | ₹1,049.31 million |
| Profit before tax | ₹1,050.84 million | ₹1,033.90 million | ₹818.99 million |
| Profit after tax | ₹885.93 million | ₹767.78 million | ₹655.06 million |
On a sequential basis, revenue grew marginally by 3% compared to the fourth quarter of FY26, which stood at ₹4,604.13 million. However, EBITDA declined slightly quarter-on-quarter to ₹1,260.88 million from ₹1,273.68 million in Q4FY26, indicating some pressure on operating margins despite higher revenue. Net profit, however, improved sequentially by 15% to ₹885.93 million from ₹767.78 million.
What the Numbers Show
The divergence between EBITDA and PAT trends warrants attention. While EBITDA contracted slightly on a quarterly basis, net profit expanded significantly. This suggests that non-operating factors or lower tax provisions may have contributed to the bottom-line growth in Q1FY27 relative to Q4FY26. Year-on-year, both top-line and bottom-line metrics show strong momentum, with PAT growing faster than revenue, signaling improved operational leverage over the past year. The company’s focus on consolidation and continued execution across its hospital network appears to be yielding positive financial outcomes.
Historical Stock Returns for Park Medi World
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.32% | +2.59% | -1.03% | +81.03% | +92.53% | +92.53% |
What specific operational or non-operating factors drove the divergence between the slight sequential EBITDA decline and the 15% increase in net profit?
How does Park Medi World plan to sustain its current margin expansion trajectory amidst rising healthcare input costs and competitive pressures in the Indian hospital sector?
Will the company accelerate its expansion strategy for its 17-hospital network in FY27 to capitalize on the improved profitability, or will it prioritize debt reduction and balance sheet strengthening?


































